Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Porter

Showing results (651-660 of 764) with videos related to

Pageof 77
Sort By:
Journal of Medicinal Chemistry|August 16, 1996
New low-density lipoprotein receptor upregulators acting via a novel mechanismM J Ashton, T J Brown, G Fenton, et al.
American Journal of Hematology|October 28, 2014
Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamineDudley J Pennell, John B Porter, Antonio Piga, et al.
American Heart Journal|July 1, 2008
Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathySharie B Parks, Jessica D Kushner, Deirdre Nauman, et al.
Scientific Reports|February 28, 2017
Non-invasive MRI biomarkers for the early assessment of iron overload in a humanized mouse model of β-thalassemiaLaurence H Jackson, Evangelia Vlachodimitropoulou, Panicos Shangaris, et al.
Journal of Clinical Microbiology|February 22, 2019
Rapid Emergence, Subsidence, and Molecular Detection of <i>Escherichia coli</i> Sequence Type 1193-<i>fimH64</i>, a New Disseminated Multidrug-Resistant Commensal and Extraintestinal PathogenJames R Johnson, Brian D Johnston, Stephen B Porter, et al.
American Journal of Hematology|February 1, 2017
New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: Results of the randomized, phase II ECLIPSE studyAli T Taher, Raffaella Origa, Silverio Perrotta, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|May 22, 2013
Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiproneJohn B Porter, John Wood, Nancy Olivieri, et al.
Advances in Radiation Oncology|February 2, 2019
Analysis of MRI Volumetric Changes After Hypofractionated Stereotactic Radiation Therapy for Benign Intracranial NeoplasmsKathryn R Fega, Geoffrey P Fletcher, Mark R Waddle, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 31, 2007
Myocardial tissue characterization and the role of chronic anemia in sickle cell cardiomyopathyMark A Westwood, Farrukh Shah, Lisa J Anderson, et al.
Arthritis Research & Therapy|June 9, 2019
Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparisonJ Braun, H Haibel, M de Hooge, et al.
Pageof 77

Showing results (651-660 of 764) with videos related to

Sort By:
Pageof 77
Journal of Medicinal Chemistry|August 16, 1996
New low-density lipoprotein receptor upregulators acting via a novel mechanismM J Ashton, T J Brown, G Fenton, et al.
American Journal of Hematology|October 28, 2014
Sustained improvements in myocardial T2* over 2 years in severely iron-overloaded patients with beta thalassemia major treated with deferasirox or deferoxamineDudley J Pennell, John B Porter, Antonio Piga, et al.
American Heart Journal|July 1, 2008
Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathySharie B Parks, Jessica D Kushner, Deirdre Nauman, et al.
Scientific Reports|February 28, 2017
Non-invasive MRI biomarkers for the early assessment of iron overload in a humanized mouse model of β-thalassemiaLaurence H Jackson, Evangelia Vlachodimitropoulou, Panicos Shangaris, et al.
Journal of Clinical Microbiology|February 22, 2019
Rapid Emergence, Subsidence, and Molecular Detection of <i>Escherichia coli</i> Sequence Type 1193-<i>fimH64</i>, a New Disseminated Multidrug-Resistant Commensal and Extraintestinal PathogenJames R Johnson, Brian D Johnston, Stephen B Porter, et al.
American Journal of Hematology|February 1, 2017
New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: Results of the randomized, phase II ECLIPSE studyAli T Taher, Raffaella Origa, Silverio Perrotta, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|May 22, 2013
Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiproneJohn B Porter, John Wood, Nancy Olivieri, et al.
Advances in Radiation Oncology|February 2, 2019
Analysis of MRI Volumetric Changes After Hypofractionated Stereotactic Radiation Therapy for Benign Intracranial NeoplasmsKathryn R Fega, Geoffrey P Fletcher, Mark R Waddle, et al.
Journal of Magnetic Resonance Imaging : JMRI|August 31, 2007
Myocardial tissue characterization and the role of chronic anemia in sickle cell cardiomyopathyMark A Westwood, Farrukh Shah, Lisa J Anderson, et al.
Arthritis Research & Therapy|June 9, 2019
Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparisonJ Braun, H Haibel, M de Hooge, et al.
Pageof 77